InvestorsHub Logo
Followers 28
Posts 2529
Boards Moderated 0
Alias Born 05/08/2015

Re: None

Sunday, 07/26/2020 7:39:44 PM

Sunday, July 26, 2020 7:39:44 PM

Post# of 232333
LERONLIMAB PATIENTS HAD 63% LESS SERIOUS ADVERSE EVENTS THAN CONTROL SUBJECTS IN MILD-TO-MODERATE PATIENTS

My comments are just my opinions and should NOT be taken as investment advice.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News